Danish Pharmacovigilance Update, 20 December 2012

17 January 2013

In this issue of Danish Pharmacovigilance Update:

  • The Danish Health and Medicines Authority encourages doctors to be aware of suspected long-term adverse reactions from the use of SSRIs in children and adolescents (front page)
  • New recommendations for spray application of the tissue adhesive Evicel® (p 2)
  • Please report any suspected excessive use or abuse of medicinal products to the Danish Health and Medicines Authority (p 3)
  • Reminder of the risk of renal impairment in association with the use of allopurinol (Allopurinol "DAK" and others) (p 4)
  • Gathering knowledge of adverse reactions from the use of biological drugs in children (p 5)
  • A new report compares adverse reaction reports from medicine users and relatives with reports from healthcare professionals (p 5)
  • Danish Medicines Act available on our website (p 6)

Did you get answers to your questions?

Please tell us how we can improve our website? Please note that we do not answer questions asked via this feature.